Interpretation of Chinese guidelines for the management of hypertension (2018 revised edition)WANG Zeng-wu, WANG Wen193-197
Progress in diagnosis and treatment of patent ductus arteriosusCHANG Qian, DAI Hai-long, GUANG Xue-feng203-206
The risk assessment of atherosclerotic cardiovascular disease and its inspiration for prevention and treatment of hypertension in ChinaXU Jia-chun, CHANG Jin, GONG Hai-bin207-210,241
Serum biomarkers in diagnostic and prognostic evaluation of acute aortic dissectionYU Hai-bin, MA Xiang, CAO Wen, HUANG Wei211-217
Clinical efficacy and safety of Nano stent in treatment of coronary heart diseaseHUANG Feng-jiao, ZHANG Hua, ZHENG Ruo-long, CHEN Xin-jun, YANG Zeng-xin, LU Tao218-222
Changes and clinical significance of serum Chemerin and hs-CRP level in patients with coronary heart diseaseLI Xiao-lin, CHENG Wei-ning, HUANG Long-hu, ZHU Jing, LI Da-zhu223-226
Clinical analysis on the recurrence after radiofrequency catheter ablation for persistant atrial fibrillationYU Hong-xiao, YU Bo, MA Chun-yan, ZHU Xiao-long, HOU Shi-yuan227-230
Application of SmartTouchTM Catheter and Visitag technology in atrial fibrillation catheter ablationZHOU Yuan-lin, ZHANG Wen-yong, LIU Jian-xiong, HU Yong-mei231-235
Evaluation of right ventricular function in patients with pulmonary hypertension by real-time three-dimensional echocardiography and velocity vector imagingGAO Hai-ye, WANG Xiao-juan, PENG Rui, LIU Tian-tui, DENG Ai-yun, ZHANG Zheng, BAI Ming236-241
